References
- Atal CK, Dubey RK, Singh J. (1985). Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther 232:258–62
- Bae GS, Kim MS, Jung WS, et al. (2010). Inhibition of lipopolysaccharide-induced inflammatory responses by piperine. Eur J Pharmacol 642:154–62
- Bai YF, Xu H. (2000). Protective action of piperine against experimental gastric ulcer. Acta Pharmacol Sin 21:357–9
- Bano G, Raina RK, Zutshi U, et al. (1991). Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol 41:615–17
- Bano G, Amla V, Raina RK, et al. (1987). The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers. Planta Med 53:568–9
- Carrasco-Portugal Mdel C, Aguilar-Cota ME, Pérez-Urizar J, et al. (2002). Bioavailability of a formulation containing a diclofenac-ranitidine combination. Proc West Pharmacol Soc 45:8–10
- Davies NM, Anderson KE. (1997). Clinical pharmacokinetics of diclofenac therapeutic insights and pitfalls. Clin Pharmacokinet 33:184–213
- Evans AM. (2000). Influence of dietary components on the gastrointestinal metabolism and transport of drugs. Ther Drug Monit 22:131–6
- Fakeye TO, Adegoke AO, Omoyeni OC, Famakinde AA. (2007). Effects of water extract of Hibiscus sabdariffa, Linn (Malvaceae) ‘Roselle’ on excretion of a diclofenac formulation. Phytother Res 21:96–8
- Gupta SK, Bansal P, Bhardwaj RK, Velpandian T. (2000). Comparative anti-nociceptive, anti-inflammatory and toxicity profile of nimesulide vs nimesulide and piperine combination. Pharmacol Res 41:657–62
- Han HK. (2011). The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs. Expert Opin Drug Metab Toxicol 7:721–9
- Hippisley-Cox J Coupland C, Logan R. (2005). Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 331:1310–16
- Hynninen VV, Olkkola KT, Leino K, et al. (2007). Effect of voriconazole on the pharmacokinetics of diclofenac. Fundam Clin Pharmacol 21:651–6
- Jiménez-Andrade JM, Ortiz MI, Pérez-Urizar J, et al. (2003). Synergistic effects between codeine and diclofenac after local, spinal and systemic administration. Pharmacol Biochem Behav 76:463–71
- Khajuria A, Zutshi U, Bedi KL. (1998). Permeability characteristics of piperine on oral absorption – an active alkaloid from peppers and a bioavailability enhancer. Indian J Exp Biol 36:46–50
- Khajuria A, Thusu N, Zutshi U. (2002). Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomedicine 9:224–31
- Kovarik JM, Kurki P, Mueller E, et al. (1996). Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction. J Rheumatol 23:2033–8
- Krösser S, Neugebauer R, Dolgos H, et al. (2006). Investigation of sarizotan's impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial. Eur J Clin Pharmacol 62:277–84
- Meghwal M, Goswami TK. (2013). Piper nigrum and piperine: an update. Phytother Res 27:1121–30
- Meng Q, Liu K. (2014). Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters. Curr Drug Metab 15:791–807
- Mohutsky MA, Anderson GD, Miller JW, Elmer GW. (2006). Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo. Am J Ther 13:24–31
- Mujumdar AM, Dhuley JN, Deshmukh VK, et al. (1990). Anti-inflammatory activity of piperine. Jpn J Med Sci Biol 43:95–100
- Pattanaik S, Hota D, Prabhakar S, et al. (2009). Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients. Phytother Res 23:1281–6
- Pattanaik S, Hota D, Prabhakar S, et al. (2006). Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy. Phytother Res 20:683–6
- Pedrazzoli Júnior J, Pierossi Mde A, Muscará MN, et al. (1997). Short-term sucralfate administration alters potassium diclofenac absorption in healthy male volunteers. Br J Clin Pharmacol 43:104–8
- Rajnarayana K, Venkatesham A, Krishna DR. (2007). Bioavailability of diclofenac sodium after pretreatment with diosmin in healthy volunteers. Drug Metabol Drug Interact 22:165–74
- Rezaee MM, Kazemi S, Kazemi MT, et al. (2014). The effect of piperine on midazolam plasma concentration in healthy volunteers, a research on the CYP3A-involving metabolism. Daru 22:8
- Sabina EP, Nagar S, Rasool M. (2011). A role of piperine on monosodium urate crystal-induced inflammation – an experimental model of gouty arthritis. Inflammation 34:184–92
- Srinivasan K. (2007). Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Crit Rev Food Sci Nutr 47:735–48
- Ushijima K, Tsuruoka S, Tsuda H, et al. (2009). Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjects. Br J Clin Pharmacol 68:194–200
- Velpandian T, Jasuja R, Bhardwaj RK, et al. (2001). Piperine in food: interference in the pharmacokinetics of phenytoin. Eur J Drug Metab Pharmacokinet 26:241–7
- Wilkinson GR. (1997). The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans. Adv Drug Deliv Rev 27:129–59
- Willis JV, Kendall MJ, Jack DB. (1980). A study of the effect of aspirin on the pharmacokinetics of oral and intravenous diclofenac sodium. Eur J Clin Pharmacol 18:415–18
- Zutshi RK, Singh R, Zutshi U, et al. (1985). Influence of piperine on rifampicin blood levels in patients of pulmonary tuberculosis. J Assoc Physicians India 33:223–4